Fireside Chat with Sean Duffy

<p>Drug discovery has doubled the flow of candidates, but approvals remain roughly flat. The constraint is development, not discovery. </p><p>In this episode, a16z General Partner, Jorge Conde talks with Formation Bio cofounder and CEO Ben Liu about building a modern pharma compa ... Show More

<p>Josh Weiner left Meta to return to CVS Health with two painful realizations: consumers don't manage their health—they expect it, and the healthcare market fundamentally violates every principle of economics. In this conversation with a16z's Julie Yoo, the CVS Senior VP explain ... Show More

<p>For the first time in human history, we can diagnose thousands of genetic diseases—often for under $1,000—but we still can't treat most of them. The problem isn't understanding what's broken; it's delivering the fix to the right cells.</p><p>Eric Kelsic, CEO of Dyno Therapeuti ... Show More

There is a revolution unfolding in biotech. The confluence of new biological methods like CRISPR, virtually unlimited computational capacity, and machine learning has fundamentally transformed our ability to engineer biology for wide-ranging applications. Andreessen Horowitz, or ... Show More

Biotechnology is the use of biology in the production of new products, services, and organisms with the aim of improving human health and society. In 2024, the global biotech market was worth $1.68 trillion. By application, the health segment was responsible for just over half of ... Show More

The late Steve Jobs of Apple said “I think the biggest innovation of the 21st century will be at the intersection of biology and technology, a new era is beginning”. If you want see how biotech can change the world of health, whilst potentially being capable of creating extraordi ... Show More

<p>Vijay Pande, founding general partner, and Julie Yoo, general partner at a16z Bio + Health, come together to discuss the grand challenges facing healthcare AI today.</p><p>The talk through the implications of AI integration in healthcare workflows, AI as a potential catalyst f ... Show More

India’s gaming industry is experiencing growth, driven by millions of players, a rapidly expanding esports culture, and increasing investments in game development. However, behind this success lies a complex landscape of regulatory challenges, evolving technology, and changing pl ... Show More

<p>Today's guest is Steve Jones, Executive Vice President of Data Driven Business & GenAI at Capgemini. Together with Emerj Senior Editor Matthew DeMello, Steve joins us on today's program to examine the evolving landscape of AI development and the critical need for trust and eth ... Show More

<p>In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. Vijay Pande, a general partner at Andreessen Horowitz (A16Z) where he leads investments in health care and life sciences. The conversation explores Pande’s journey from academia to venture ca ... Show More

In this bonus episode of Inside the Strategy Room, we feature an interview with OpenAI CFO Sarah Friar from the At the Edge podcast. Sarah joined our senior partner, Lareina Yee, to discuss how to lead through this era of intense technological change and what it means for the fut ... Show More